Amrize Q2 revenue climbs 8.6% to $3.49B, but material weakness and a prior-period revision persist

summarizeSummary

Amrize's Q2 2026 revenue grew 8.6% to $3.49 billion, with net income of $476 million. The filing also reveals a prior-period revision and an ongoing material weakness in internal controls.

check_boxKey Events · Earnings and Guidance · AMRZ

• Q2 Revenue Up 8.6%

  Revenue reached $3.49 billion, driven by volume growth of $200 million and contributions from acquisitions of $54 million. Net income was $476 million, up from $416 million a year ago.

• Prior Period Revision

  The company revised prior financial statements to correct an understatement of deferred revenue related to extended warranties, which was $78 million as of December 31, 2025. The correction was not material to any prior period but would be material to current results.

• Material Weakness Unresolved

  The previously disclosed material weakness in internal controls over financial reporting, related to insufficient U.S. GAAP expertise, remains unremediated. Management is continuing remediation efforts.

• Share Buyback Active

  Amrize repurchased $194 million of shares in Q2 under its $1 billion authorization, with $0.8 billion remaining. The stock closed at $53.30 on June 30, 2026, implying 15.1 million shares remaining under the program.

auto_awesomeAnalysis · AMRZ · Manufacturing

Solid Q2 results saw revenue rise 8.6% to $3.49 billion and net income reach $476 million, fueled by volume growth in Building Materials. Yet the quarter also brought a prior-period revision tied to an understatement of deferred revenue from extended warranties, and the material weakness in internal controls remains unremediated. With the stock trading near its 52-week low, the active $1 billion buyback program offers some support, but the control deficiencies and accounting corrections inject uncertainty.